ARCT
Arcturus Therapeutics Holdings Inc.
24.71
USD
This page is just a preview of the data found in TrendSpider’s full version
Arcturus Therapeutics Holdings Inc. stock is up 26.2% since 30 days ago. The next earnings date is Mar 26, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 36.36% of the previous 10 December’s closed higher than November. In the last 8 Unusual Options Trades, there were 3 PUTs, 5 CALLs. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 30 Oct 19:05 | 17 Nov, 2023 | 30.00 | 357 | ||
| 30 Oct 19:05 | 17 Nov, 2023 | 30.00 | 357 | ||
| 15 Nov 14:43 | 15 Dec, 2023 | 25.00 | 335 | ||
| 17 Nov 14:38 | 19 Jan, 2024 | 25.00 | 466 | ||
| 17 Nov 19:17 | 19 Jan, 2024 | 20.00 | 394 | ||
| 17 Nov 19:18 | 19 Jan, 2024 | 20.00 | 394 | ||
| 17 Nov 19:19 | 19 Jan, 2024 | 20.00 | 394 | ||
| 28 Nov 15:06 | 15 Dec, 2023 | 22.50 | 236 |
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNar-CF program for cystic fibrosis lung disease. It has collaboration partnerships with Vinbiocare Biotechnology Joint Stock Company for the manufacture of COVID-19 vaccines.
